- Shop Products
- Services & Tools
- Business Resources
- Clinical Resources
- About Us
- Contact Us
Do you have questions about the flu vaccine or about working with McKesson Medical-Surgical to purchase your flu vaccine? Read through some of our most frequently asked questions to find the answers you need. We are committed to providing you with the knowledge you need to make the best decisions for the people you serve.
Manufacturers plan vaccine production based on historical information and current season pre-books. Pre-booking is necessary to make sure you get your product. Historical data shows that manufacturers typically waitlist certain vaccines in March. Once a product is waitlisted, there is no guarantee of a delivery date or even that more vaccines will be available. Product may be limited in supply to providers who did not take advantage of the pre-book period.
Because of the lengthy flu vaccine manufacturing and distribution periods, as well as limited quantities, it’s best to pre-book and order your vaccine as early as possible. Typically, you would want to order your vaccine in the spring, shortly after the season’s vaccines and strains are announced by the FDA and CDC.
Assess your last year’s vaccine usage and make adjustments as necessary. Take into consideration any expected flu surges in your area, as well as your patient population. Certain persons are at a higher risk of medical complications attributable to severe flu, so you should assess your patient population for these persons and include these numbers in your vaccine ordering. Persons at risk include:1
When a flu booking is Waitlisted, this means that the manufacturer has reached capacity and we may not receive additional quantity for that vaccine to fill newer pre-books. We will make every effort to fill your order, but cannot guarantee availability. Many times, we are able to fill Waitlisted orders if other customers cancel their booking for that product. Our portfolio offers you the ability to access multiple products as a safety net.
You may pre-book for the next season at any time. Pricing is typically set in January for the coming season. You have until July to change or cancel your pre-books with no penalty when you pre-book with McKesson Medical-Surgical.
McKesson Medical-Surgical will contact you by phone or email when your flu vaccine is available for shipment. We ship flu vaccine based on manufacturer availability and the order in which pre-books were received. Please make sure to update your contact information by contacting email@example.com to ensure we are able to reach you.
Fluzone® Intradermal QIV is the only pre-filled syringe that includes a needle.
Yes. McKesson Medical-Surgical carries several flu vaccines that do not contain Thimerosal. All of our detailed product information is found on the online Flu Vaccine Formulary.
Yes. McKesson Medical-Surgical offers Flublok® as an egg-free option.
Yes. McKesson Medical-Surgical offers FluMist® QIV Nasal Spray as a Live Vaccine option.
Our influenza portfolio encompasses all influenza vaccines. If there is a manufacturer delay, our portfolio offers you the ability to access multiple products as a safety net. We implement a distribution strategy developed with the goal of enabling as many providers as possible to begin vaccination activities early in the season. Our Flu Connection Team is fully committed to respond to your needs.
Different flu vaccine preparations have different indications as approved by the FDA.3 Click here to see the CDC’s breakdown of the different types of flu vaccines available.
According to the CDC, quadrivalent refers to the number of strains of influenza virus contained in the vaccine – four strains – two “A” and two “B”. High dose is a type of vaccine that provides a more robust immune response in patients 65 years and older.4
According to the CDC, people 65 years and older can get any injectable vaccine (flu shot) that is approved for use in that age group.4 However, there are two vaccines designed and indicated specifically for people 65 and older, Fluzone® High-Dose manufactured by Sanofi-Pasteur and Fluad® manufactured by Seqirus.
Look for the season’s strains in late February/early March. The World Health Organization (WHO) consults with various experts and partners each year in February, before making recommendations for the composition of the seasonal influenza vaccine. Shortly thereafter, the Food and Drug Administration (FDA) likely endorses this recommendation and announces which strains the season’s vaccine will protect against.4